The effect of brief behavioral activation treatment on symptoms of depression, mental health and quality of life among the patients with opioid abuse

authors:

avatar Jafar Hasani 1 , avatar Hadi Parhoon 1 , avatar Khodamorad Momeni 2 , *

Dept. of Clinical Psychology, Kharazmi University, Tehran, Iran
Dept. of Psychology, Razi University, Kermanshah, Iran

how to cite: Hasani J, Parhoon H, Momeni K. The effect of brief behavioral activation treatment on symptoms of depression, mental health and quality of life among the patients with opioid abuse. J Kermanshah Univ Med Sci. 2015;19(2):e70706. https://doi.org/10.22110/jkums.v19i2.2209.

Abstract

Background: Depression is one of the most common mental disorders comorbid with  with substance use disorder. This research was aimed to evaluate the effect of brief behavioral activation treatment on the symptoms of depression, mental health and quality of life among the patients with opioid use disorders.
Methods: In a quasi-experimental study with pretest-posttest control group design, 24 patients taking opiates were selected through convenience sampling method and randomly assigned into experimental and control groups. The experimental group was treated for two months. BDI-II, GHQ-28, WHOQOL-BREF were given to both groups before and after treatment and in the 2-month followup period. The results were analyzed using mixed analysis of variance.
Results: The results showed that brief behavioral activation treatment significantly reduced the symptoms of depression (P<0.01) and increased mental health (p<0.01) in the experimental group in the post-test and follow-up phases, but had no significant impact on the patients’ quality of life (P>0.05).
Conclusion: brief behavioral activation treatment is capable of reducing the severity of symptoms of depression and improving the mental health of patients with substance use disorders.

Fulltext

References

  • 1.

    The references of this article is available on PDF.